Skip to main content
Premium Trial:

Request an Annual Quote

Noel Doheny, Jerry Williamson, Vivian Cheung, Ivan Baines, Peter Lichter, Klaus Schmidt-Meschner

Premium
OpGen has hired Noel Doheny to take over as CEO and as a member of the company’s board of directors. Doheny recently was senior vice president of molecular diagnostics at Affymetrix, and he has been in leadership roles at Biostar, Qiagen, and Ciba-Corning.  
 

 
Genetix Group has appointed Jerry Williamson to the post of president of US operations, a new position. Williamson formerly served as president of Biacore, was president of the genomics company Pyrosequencing, and was in commercial management at Genzyme and at Roche Laboratories.
 

 
Vivian Cheung has been named an investigator by the Howard Hughes Medical Institute. Cheung, who is a pediatric neurologist at the Children’s Hospital of Philadelphia and the University of Pennsylvania School of Medicine, studies the links between gene expression and individual susceptibility to disease and treatment responses.
 

 
ImaGenes has appointed Ivan Baines, Peter Lichter, and Klaus Schmidt-Meschner to its advisory board. Baines is director of services and facilities at the Max Planck Institute for Molecular Cell Biology in Dresden. Lichter is an array technology expert at the German Cancer Research Center in Heidelberg. Schmidt-Menschner formerly was an executive at Bayer AG.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.